Andojon, Ruth .
HRN: 28-21-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/09/2025
12/21/2025
IV
4.5g
Q8h
T/C Intraabdominal Infection
Checking Final Appropriateness
12/20/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/20/2025
12/26/2025
IV
500mg
Q8
SP Exlap
Checking Initial Appropriateness